UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000013783 |
|---|---|
| Receipt number | R000016089 |
| Scientific Title | A phase2 trial of dose-adjusting Capecitabine plus stopped Oxaliplatin after six cycles in a XELOX regimen with Bevacizumab for untreated metastatic colorectal cancer. (GOSG C-04 trial) |
| Date of disclosure of the study information | 2014/04/23 |
| Last modified on | 2018/10/28 09:57:02 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/04/22 15:19:49 | ||
| 2 | Update | 2018/10/28 09:57:02 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
